Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Genomics

Background:

• Type 2 diabetes mellitus (DM) significantly increases ischemic heart disease risk.
• The molecular mechanisms underlying diabetic ischemic heart disease are not fully understood.
• Long noncoding RNAs (lncRNAs) play roles in cardiovascular conditions, but their function in diabetic heart disease is unclear.

Purpose of the Study:

• To investigate lncRNA expression profiles in a mouse model of type 2 diabetes with ischemic heart disease.
• To identify specific lncRNAs that are differentially expressed after myocardial infarction (MI) in diabetic mice.

Main Methods:

• Unbiased RNA sequencing was performed on left ventricular (LV) tissues from type 2 DM (db/db) and control (db/+) mice subjected to sham or MI surgery.
• Computational analysis identified differentially expressed lncRNAs between groups.

Main Results:

• Several lncRNAs were differentially expressed in diabetic mice after MI compared to controls.
• Gm19522 and Gm8075 were identified as significantly downregulated post-MI in diabetic mice.
• Gm19522 is potentially involved in DNA replication, while Gm8075 is linked to cancer gene dysregulation and PI3K/Akt pathways.

Conclusions:

• The identified lncRNAs, Gm19522 and Gm8075, show altered expression in diabetic ischemic heart disease.
• These lncRNAs may serve as potential biomarkers for cardiac repair or novel therapeutic targets in diabetic ischemic heart disease.